(Q33804132)

29 July 2017

1 reference

title

TGF-beta in infections and infectious diseases (English)

1 reference

29 July 2017

1 reference

S G Reed

1

1 reference

29 July 2017

publication date

1 December 1999

1 reference

29 July 2017

published in

Microbes and Infection

1 reference

29 July 2017

volume

1

1 reference

29 July 2017

issue

15

1 reference

29 July 2017

page(s)

1313-1325

1 reference

Interleukin 10 production correlates with pathology in human Leishmania donovani infections

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Deactivation of macrophages by transforming growth factor-β

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta).

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

An immunoaffinity-purified Trypanosoma cruzi antigen suppresses cellular proliferation through a TGF-beta-mediated mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Trypanosome invasion of mammalian cells requires activation of the TGF beta signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Interleukin-2 suppresses activated macrophage intracellular killing activity by inducing macrophages to secrete TGF-beta.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Transforming growth factor-beta inhibits interleukin-12-induced production of interferon-gamma by natural killer cells: a role for transforming growth factor-beta in the regulation of T cell-independent resistance to Toxoplasma gondii.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Transforming growth factor beta production is inversely correlated with severity of murine malaria infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Enhancement Of Intracellular Growth Of Mycobacterium Tuberculosis In Human Monocytes by Transforming Growth Factor- l

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Induction of transforming growth factor beta 1 by purified protein derivative of Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Cross-modulation by transforming growth factor beta in human tuberculosis: suppression of antigen-driven blastogenesis and interferon gamma production

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Altered cytokine production and impaired antimycobacterial immunity in protein-malnourished guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Infection of murine macrophages with Toxoplasma gondii is associated with release of transforming growth factor beta and downregulation of expression of tumor necrosis factor receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Transforming growth factor beta (TGF-b1) plays a detrimental role in the progression of experimental Mycobacterium avium infection; in vivo and in vitro evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Activation of latent transforming growth factor beta during Chlamydia trachomatis-induced murine pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Human cytomegalovirus infection induces transcription and secretion of transforming growth factor beta 1

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Transforming growth factor beta production during rat cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Histological features predictive of liver fibrosis in chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Transforming growth factor-beta 1 in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Neutralization of transforming growth factor beta 1 augments hepatitis C virus-specific cytotoxic T lymphocyte induction in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Parainfluenza virus-induced persistence of airway inflammation, fibrosis, and dysfunction associated with TGF-beta 1 expression in brown Norway rats

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Influenza virus neuraminidase activates latent transforming growth factor beta.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Transforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

TGF beta and HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Transforming growth factor-beta and suppression of humoral immune responses in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Increased levels of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) mRNA expressing blood mononuclear cells in human HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

TGF-beta: upregulator of HIV replication in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

The replicative restriction of lymphocytotropic isolates of HIV-1 in macrophages is overcome by TGF-beta

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Recombinant human immunodeficiency virus type-1 (HIV-1) Tat protein sequentially up-regulates IL-6 and TGF-beta 1 mRNA expression and protein synthesis in peripheral blood monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

HIV-1 gp160 induces transforming growth factor-beta production in human PBMC

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Inhibition of human immunodeficiency virus type 1 multiplication by transforming growth factor beta 1 and AZT in HIV-1-infected myeloid cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

Plasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

TGF-beta: a balancing act.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900252-X

7 January 2021

10.1016/S1286-4579(99)00252-X

Identifiers

DOI

1 reference

29 July 2017

1 reference